Treace Medical Concepts, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
TMCI on Nasdaq
Location
100 Palmetto Park Place, Ponte Vedra, Florida

Insiders trading volume in the past year

Treace Medical Concepts, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John Treace Chief Executive Officer, Director, 10%+ Owner $70.8M +$3.47M +5.15% Aug 14, 2024
John R. Treace Director $59.2M May 9, 2022
Thomas Timbie Director $40.1M Mar 15, 2023
Joe W. Ferguson SVP, Research & Development $13.4M Oct 6, 2021
James Treace Director $10.6M +$2.07M +24.2% Aug 15, 2024
Jaime Frias Chief Legal Officer $7.32M Mar 8, 2022
Richard W. Mott Director $5.57M +$695K +14.2% May 24, 2024
John K. Bakewell Director $2.74M +$595K +27.7% May 21, 2024
Mark Hair Chief Financial Officer $2.17M Aug 9, 2024
Scot Elder Chief Legl & Comp Off, CorpSec $1.4M Aug 9, 2024
Sean Scanlan Chief Innovation Officer $1.27M Aug 9, 2024
Aaron Berutti SVP, Sales $975K Aug 9, 2024
Daniel E. Owens Chief Human Resources Officer $820K Mar 15, 2023
Deepti Jain Director $258K +$113K +77.6% May 21, 2024
Jane E. Kiernan Director $223K +$100K +81.5% May 21, 2024
Terry W. Lubben SVP, Operations $155K Mar 8, 2022
Betsy Hanna Director $119K May 21, 2024
Lance A. Berry Director $115K May 21, 2024
Lawrence Hamilton Director $112K May 21, 2024
F. Barry Bays Former Director Jun 2, 2023

Recent Insider Transactions by Companies or Individuals for Treace Medical Concepts, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.